Tag: locoregionalRecurrence

Articles

• Prognosis of triple negative breast cancer compared to other subtypes

News

01/20/13

Some BC types have up to 11% locoregional recurrence after mastectomy

08/12/12

Lymph node negative ER-/PR- BC has less favorable prognosis

04/18/12

Breast cancer survivors at higher risk of new breast tumors

03/19/12

Risk of DCIS relapse or progression continues at least 20 years

08/05/11

Mexican breast cancer patients are younger & more likely to have TN BC

08/01/11

BC subtype influences prognosis after neoadjuvant chemotherapy

03/17/11

Radiation after lumpectomy reduces recurrence for DCIS survivors

03/02/11

Risk of second primary breast cancer highest in ER-/PR- survivors

03/22/10

Breast reduction surgery may be combined with lumpectomy for DCIS

Studies

• Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I–III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial Cite
  Glass CC, Pride RM, Freedman RA, Mayer EL, Ogayo ER, Chavez-MacGregor M, et al. Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I–III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-14220-w
• Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy Cite
  Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, et al. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13906-5
• Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer Cite
  Kantor O, King TA, Freedman RA, Mayer EL, Chavez-MacGregor M, Korde LA, et al. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer. JAMA Surgery. American Medical Association (AMA); 2023; 10.1001/jamasurg.2023.0297
• Abstract PD6-10: PD6-10 The impact of post mastectomy radiation therapy on clinical outcomes of male breast cancer: A meta-analysis of comparative studies Cite
  Haddad PA, Zaheer U. Abstract PD6-10: PD6-10 The impact of post mastectomy radiation therapy on clinical outcomes of male breast cancer: A meta-analysis of comparative studies. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:PD6-10-PD6-10 10.1158/1538-7445.sabcs22-pd6-10
• The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy Cite
  Vrieling C, Assele SY, Moser L, Sauvé N, Litière S, Fourquet A, et al. The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy. European Journal of Cancer. Elsevier BV; 2021; 155:28-37 10.1016/j.ejca.2021.06.018
• Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy Cite
  Falco M, Masojć B, Kram A. Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy. The Breast Journal. Wiley; 2020; 26:2364-2370 10.1111/tbj.14118
• Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials Cite
  Werutsky G, Untch M, Hanusch C, Fasching PA, Blohmer J, Seiler S, et al. Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials. European Journal of Cancer. Elsevier BV; 2020; 130:92-101 10.1016/j.ejca.2020.02.015
• Risk factors for locoregional recurrence (LRR) after neoadjuvant chemotherapy: Pooled analysis of prospective neoadjuvant breast cancer (BC) trials Cite
  Werutsky G, Untch M, Hanusch C, Fasching P, Blohmer J, Seiler S, et al. Risk factors for locoregional recurrence (LRR) after neoadjuvant chemotherapy: Pooled analysis of prospective neoadjuvant breast cancer (BC) trials. Annals of Oncology. Elsevier BV; 2019; 30:v62-v63 10.1093/annonc/mdz240.014
• Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study Cite
  van Maaren MC, de Munck L, Strobbe LJ, Sonke GS, Westenend PJ, Smidt ML, et al. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study. International Journal of Cancer. Wiley; 2018; 144:263-272 10.1002/ijc.31914
• Obesity and mortality after locoregional breast cancer diagnosis Cite
  Moore AH, Trentham-Dietz A, Burns M, Gangnon RE, Greenberg CC, Vanness DJ, et al. Obesity and mortality after locoregional breast cancer diagnosis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:647-657 10.1007/s10549-018-4932-6
• Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype Cite
  McGuire A, Lowery AJ, Kell MR, Kerin MJ, Sweeney KJ. Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:3124-3132 10.1245/s10434-017-6021-1
• Patterns and predictors of first and subsequent recurrence in women with early breast cancer Cite
  Geurts YM, Witteveen A, Bretveld R, Poortmans PM, Sonke GS, Strobbe LJA, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:709-720 10.1007/s10549-017-4340-3
• Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial Cite
  Wapnir IL, Gelber S, Anderson SJ, Mamounas EP, Robidoux A, Martín M, et al. Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 24:398-406 10.1245/s10434-016-5571-y
• Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study Cite
  van Roozendaal LM, Smit LHM, Duijsens GHNM, de Vries B, Siesling S, Lobbes MBI, et al. Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:465-472 10.1007/s10549-016-3757-4
• Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer Cite
  Aalders KC, Postma EL, Strobbe LJ, van der Heiden-van der Loo M, Sonke GS, Boersma LJ, et al. Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:2107-2114 10.1200/jco.2015.64.3536
• Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database Cite
  Tseng YD, Uno H, Hughes ME, Niland JC, Wong Y, Theriault R, et al. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 93:622-630 10.1016/j.ijrobp.2015.07.006
• Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval Cite
  Witteveen A, Kwast ABG, Sonke GS, IJzerman MJ, Siesling S. Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0120832 10.1371/journal.pone.0120832
• Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 Cite
  Mamounas EP, Anderson SJ, Dignam JJ, Bear HD, Julian TB, Geyer CE, et al. Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:3960-3966 10.1200/jco.2011.40.8369
• Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction Cite
  Kneubil M, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A, et al. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2013; 39:260-265 10.1016/j.ejso.2012.12.004
• Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ Cite
  Owen D, Tyldesley S, Alexander C, Speers C, Truong P, Nichol A, et al. Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 85:e129-e134 10.1016/j.ijrobp.2012.10.020
• Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection Cite
  Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, et al. Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2012; 256:428-436 10.1097/sla.0b013e3182654494
• The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients With 1-3 Positive Axillary Nodes After Mastectomy Cite
  Harris EE, Freilich J, Lin H, Chuong M, Acs G. The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients With 1-3 Positive Axillary Nodes After Mastectomy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 85:609-614 10.1016/j.ijrobp.2012.05.050
• Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report Cite
  Karlsson P, Cole B, Chua B, Price K, Lindtner J, Collins J, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report. Annals of Oncology. Elsevier BV; 2012; 23:2852-2858 10.1093/annonc/mds118
• Biology, Treatment, and Outcome in Very Young and Older Women with DCIS Cite
  Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, et al. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:3777-3784 10.1245/s10434-012-2413-4
• Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy? Cite
  Hamamoto Y, Ohsumi S, Aogi K, Shinohara S, Nakajima N, Kataoka M, et al. Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?. Breast Cancer. Springer Science and Business Media LLC; 2012; 21:177-182 10.1007/s12282-012-0369-7
• Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy Cite
  Selz J, Stevens D, Jouanneau L, Labib A, Le Scodan R. Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 84:1123-1132 10.1016/j.ijrobp.2012.02.047
• Long-Term Outcome in Patients With Ductal Carcinoma In Situ Treated With Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies Cite
  Shaitelman SF, Wilkinson JB, Kestin LL, Ye H, Goldstein NS, Martinez AA, et al. Long-Term Outcome in Patients With Ductal Carcinoma In Situ Treated With Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:e305-e312 10.1016/j.ijrobp.2011.12.092
• Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? Cite
  Trovo M, Durofil E, Polesel J, Roncadin M, Perin T, Mileto M, et al. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:e153-e157 10.1016/j.ijrobp.2011.12.050
• Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype Cite
  Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 133:831-841 10.1007/s10549-011-1891-6
• Twenty-five year results of the national cancer institute randomized breast conservation trial Cite
  Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:197-203 10.1007/s10549-011-1867-6
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Cite
  Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 18:3164-3173 10.1245/s10434-011-1920-z
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Cite
  Buckley JM, Coopey S, Samphao S, Specht MC, Hughes KS, Gadd M, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:70-70 10.1200/jco.2011.29.27_suppl.70
• Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy. Cite
  Takita C, Reis IM, Miao F, LaFave KE, Gunaseelan V, Hurley J, et al. Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:112-112 10.1200/jco.2011.29.27_suppl.112
• Triple-negative breast cancer in Hispanic patients Cite
  Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D, Blake-Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients. Cancer. Wiley; 2011; 117:3658-3669 10.1002/cncr.25961
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
  Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
• Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes Cite
  Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 127:713-720 10.1007/s10549-011-1465-7
• Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer Cite
  Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, et al. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer. Wiley; 2010; 117:1595-1601 10.1002/cncr.25694
• Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS Cite
  Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:478-488 10.1093/jnci/djr027
• Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy Cite
  Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. Wiley; 2010; 117:916-924 10.1002/cncr.25505
• Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer Cite
  Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 20:389-396 10.1158/1055-9965.epi-10-1016
• Abstract P3-11-07: Multivitamin Use and Breast Cancer Prognosis and Survival in a Prospective Cohort Study: The Life After Cancer Epidemiology (LACE) Study Cite
  Greenlee H, Kwan M, Sweeney C, Habel L, Gunderson E, Kushi L, et al. Abstract P3-11-07: Multivitamin Use and Breast Cancer Prognosis and Survival in a Prospective Cohort Study: The Life After Cancer Epidemiology (LACE) Study. Poster Session Abstracts. American Association for Cancer Research; 2010; 10.1158/0008-5472.sabcs10-p3-11-07
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Cite
  Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:187-194 10.1007/s10549-010-1135-1
• Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Cite
  Dragun AE, Pan J, Rai SN, Kruse B, Jain D. Locoregional Recurrence in Patients With Triple-Negative Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2011; 34:231-237 10.1097/coc.0b013e3181dea993
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Cite
  van der Sangen MJC, van de Wiel FMM, Poortmans PMP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Roumen RMH, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:207-215 10.1007/s10549-010-1110-x
• The impact of young age on breast cancer outcome Cite
  Livi L, Meattini I, Saieva C, Borghesi S, Scotti V, Petrucci A, et al. The impact of young age on breast cancer outcome. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2010; 36:639-645 10.1016/j.ejso.2010.05.016
• Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001 Cite
  Joergensen L, Gunnarsdottir K, Lanng C, Moeller S, Rasmussen B. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001. The Breast. Elsevier BV; 2008; 17:587-591 10.1016/j.breast.2008.06.004
• Conservative surgery in patients with multifocal/multicentric breast cancer Cite
  Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 113:577-583 10.1007/s10549-008-9959-7
• Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Cite
  Weissenbacher TM, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 122:27-34 10.1007/s10549-010-0917-9
• Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis Cite
  Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:627-637 10.1093/jnci/djq101
• Abstract 899: Patterns of distant and local relapses in breast cancer patients and triple negative subgroup Cite
  Conson M, D'Amato G, Nieddu V, Pagliarulo C, Iorio V, Vernieri C, et al. Abstract 899: Patterns of distant and local relapses in breast cancer patients and triple negative subgroup. Epidemiology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-899
• The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy Cite
  Rudloff U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, et al. The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2010; 251:583-591 10.1097/sla.0b013e3181b5931e
• Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer Cite
  Tanis E, van de Velde C, Bartelink H, van de Vijver M, Putter H, van der Hage J. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer. European Journal of Cancer. Elsevier BV; 2012; 48:1751-1756 10.1016/j.ejca.2012.02.051
• Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence Cite
  Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, et al. Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2009; 17:772-777 10.1245/s10434-009-0804-y
• Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society Cite
  Moon H, Han W, Noh D. Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1692-1699 10.1200/jco.2009.25.9226
• Factors predicting in-breast tumor recurrence after breast-conserving surgery Cite
  Mechera R, Viehl CT, Oertli D. Factors predicting in-breast tumor recurrence after breast-conserving surgery. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 116:171-177 10.1007/s10549-008-0187-y
• Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age Cite
  Courdi A, Doyen J, Gal J, Chamorey E. Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age. Oncology. S. Karger AG; 2010; 79:349-354 10.1159/000323483